Here Comes The Sun

Nice to see, as reported this week on the front page of The Baltimore Sun, that the internationally renowned Wilmer Eye Institute at Johns Hopkins is undertaking a large study on vision and learning.  Hopkins appears poised to demonstrate that visual deficiencies can hamper educational performance.  I’ll take the point of personal privilege here, having been in practice for 38 years, to note how refreshing it is to see ophthalmologists embrace this position.  Aside from the article in the Sun, background information on the Hopkins initiative can be found here.

CITT ART LogoMore sunshine came this week in the form of a CBS-TV news segment featuring the CITT-ART.  Particularly if you’re located in a region that is accessible to the one of the eight national CITT-ART centers, please consider supporting the recruitment efforts of this crucial multi-center, NEI funded study that is a cooperative venture between Optometry and Ophthalmology.

4 thoughts on “Here Comes The Sun

  1. The devil will be in the details of the study. Will CI be among the diagnoses? Will VT be among the treatments?

  2. Frankly, does it make a difference at this point? Much like PEDIG showed that the first thing that should be done in the treatment of amblyopia is to have the optimum Rx in place and positive changes will ensue, wouldn’t you agree that before CI and VT are pursued, it is a positive step to at least link Rxing with improved academic performance? One thing I learned from the early planning from the CITT studies (at the outset, when it was CIRS), is that if you wait for the ideal study you’ll never get off the ground.

  3. I sure hope that the results of the CITT-ART study will be published in a scientific journal! If I recall, the Archives of Ophthalmology, which published the initial 2008 CITT study, wanted it to be known – within the same issue that the study was published – that it did not consider a randomized, controlled trial to be the highest level of scientific research evidence. Lest we forget the editorial by David K. Wallace, MD (Treatment options for symptomatic convergence insufficiency, Archives of ophthalmology (Impact Factor: 4.49). 11/2008; 126(10):1455-6) in this journal, personal opinion is the gold standard!

    • Well, Dr. Biberdorf, in a perfect world the results of the CITT would have resulted in a paradigm shift in pediatric ophthalmology treatment of CI instead of having been introduced with the “disclaimer” you noted. At this stage of my career I’ve transitioned into worrying less about what ophthalmology does, and focusing more on being the best that we can in all facets of research, publication, and practice. If there is synergy with ophthalmology, lovely. This latest research will be, pardon the pun, state of the ART. Where it’s various phases will be published is up to the investigator – but there may be some pleasant surprises in store.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s